Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
Clinical trial NCT06395285 · RECRUITING
Trial details
- NCT number
- NCT06395285
- Sponsor
- Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-27
- Primary completion
- 2026-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.